First immunotherapy combination of ipilimumab plus nivolumab available to patients in England
We are very pleased to learn that the ipilimumab plus [...]
We are very pleased to learn that the ipilimumab plus [...]
New 30-month survival data from the CheckMate 214 study were [...]
The results from the following study were presented at the [...]
Further survival data has been released from the phase 3 [...]
A recent study reports the real-world safety and efficacy of [...]
The following review of the literature for first-line treatment of [...]
The European Commission has approved the nivolumab plus ipilimumab combination [...]
A recent analysis of data from the phase 3 Checkmate-214 [...]
We have just learnt the news that the Committee for Medicinal Products [...]
A phase 1 study has evaluated the safety and efficacy [...]